| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| IRMDIRadimed Corporation | 1.3B | 102.57 | 68.38 | 11.71% | 26.31% | 21.54% | 1.35% | 0.00 |
| BRKRBruker Corporation | 7.52B | 49.46 | 65.08 | 13.56% | -0.61% | -0.84% | 1.81% | 1.24 |
| STESTERIS plc | 26.33B | 268.26 | 43.27 | 6.24% | 12.07% | 9.8% | 2.95% | 0.33 |
| FONRFONAR Corporation | 114.98M | 18.64 | 15.15 | 1.43% | 7.08% | 4.62% | 6.48% | 0.24 |
| HYPRHyperfine, Inc. | 100.18M | 1.22 | -2.18 | 16.84% | -378.17% | -149.05% | 0.01 | |
| PACBPacific Biosciences of California, Inc. | 709.48M | 2.35 | -2.20 | -23.19% | -325.8% | -13.95% | 1.33 | |
| IRIXIRIDEX Corporation | 23.21M | 1.35 | -2.50 | -6.17% | -10.04% | -108.67% | 2.21 | |
| MASS908 Devices Inc. | 199.79M | 5.52 | -2.60 | 18.72% | -7.17% | -3.03% | 0.06 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 22.05M | 17.97M | 26.89M | 42.21M | 46.85M | 50.23M | 59.63M |
| Revenue Growth % | - | -0.19% | 0.5% | 0.57% | 0.11% | 0.07% | 0.19% |
| Cost of Goods Sold | 9.66M | 9.83M | 11.97M | 18.97M | 20.83M | 24.91M | 29.71M |
| COGS % of Revenue | 0.44% | 0.55% | 0.45% | 0.45% | 0.44% | 0.5% | 0.5% |
| Gross Profit | 12.39M | 8.14M | 14.92M | 23.23M | 26.02M | 25.32M | 29.93M |
| Gross Margin % | 0.56% | 0.45% | 0.55% | 0.55% | 0.56% | 0.5% | 0.5% |
| Gross Profit Growth % | - | -0.34% | 0.83% | 0.56% | 0.12% | -0.03% | 0.18% |
| Operating Expenses | 18.83M | 20.29M | 20.74M | 45.3M | 61.41M | 68.08M | 106.64M |
| OpEx % of Revenue | 0.85% | 1.13% | 0.77% | 1.07% | 1.31% | 1.36% | 1.79% |
| Selling, General & Admin | 9.3M | 0 | 0 | 32.23M | 43.88M | 0 | 0 |
| SG&A % of Revenue | 0.42% | - | - | 0.76% | 0.94% | - | - |
| Research & Development | 9.53M | 8.99M | 8.23M | 13.07M | 17.53M | 21.9M | 25.5M |
| R&D % of Revenue | 0.43% | 0.5% | 0.31% | 0.31% | 0.37% | 0.44% | 0.43% |
| Other Operating Expenses | 50K | 11.29M | 12.5M | 0 | 0 | 46.18M | 81.15M |
| Operating Income | -6.44M | -12.14M | -5.82M | -22.07M | -35.38M | -42.76M | -76.72M |
| Operating Margin % | -0.29% | -0.68% | -0.22% | -0.52% | -0.76% | -0.85% | -1.29% |
| Operating Income Growth % | - | -0.89% | 0.52% | -2.8% | -0.6% | -0.21% | -0.79% |
| EBITDA | -5.54M | -11.24M | -4.98M | -21.14M | -33.77M | -40.37M | -72.04M |
| EBITDA Margin % | -0.25% | -0.63% | -0.19% | -0.5% | -0.72% | -0.8% | -1.21% |
| EBITDA Growth % | - | -1.03% | 0.56% | -3.24% | -0.6% | -0.2% | -0.78% |
| D&A (Non-Cash Add-back) | 896K | 900K | 831K | 925K | 1.61M | 2.38M | 4.68M |
| EBIT | -6.39M | -12.14M | -5.82M | -21.68M | -33.43M | -42.65M | -48.56M |
| Net Interest Income | -1.15M | -1.53M | -976K | 62K | 1.9M | 6.28M | 4.49M |
| Interest Income | 0 | 0 | 0 | 548K | 2.03M | 6.48M | 4.49M |
| Interest Expense | 1.15M | 1.53M | 976K | 486K | 129K | 201K | 0 |
| Other Income/Expense | -1.1M | -1.23M | -7M | -100K | 1.82M | 6.15M | 4.23M |
| Pretax Income | -7.54M | -13.37M | -12.82M | -22.17M | -33.56M | -36.61M | -72.49M |
| Pretax Margin % | -0.34% | -0.74% | -0.48% | -0.53% | -0.72% | -0.73% | -1.22% |
| Income Tax | 50K | 0 | 0 | 0 | 0 | -211K | -282K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 0.99% | 1% |
| Net Income | -7.54M | -13.37M | -12.82M | -22.17M | -33.56M | -36.4M | -72.21M |
| Net Margin % | -0.34% | -0.74% | -0.48% | -0.53% | -0.72% | -0.72% | -1.21% |
| Net Income Growth % | - | -0.77% | 0.04% | -0.73% | -0.51% | -0.08% | -0.98% |
| Net Income (Continuing) | -7.54M | -13.37M | -12.82M | -22.17M | -33.56M | -36.4M | -72.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.93 | -2.02 | -2.35 | -0.79 | -1.07 | -1.13 | -2.12 |
| EPS Growth % | - | -1.17% | -0.16% | 0.66% | -0.35% | -0.06% | -0.88% |
| EPS (Basic) | -0.93 | -2.02 | -2.35 | -0.79 | -1.07 | -1.13 | -2.12 |
| Diluted Shares Outstanding | 8.12M | 7.53M | 5.49M | 27.96M | 31.49M | 32.24M | 34.08M |
| Basic Shares Outstanding | 8.12M | 7.53M | 5.49M | 27.96M | 31.49M | 32.21M | 34.08M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 17.2M | 28.58M | 170.97M | 252.89M | 215.63M | 173.79M | 103.06M |
| Cash & Short-Term Investments | 7.07M | 17.91M | 159.23M | 224.07M | 188.42M | 145.68M | 69.6M |
| Cash Only | 7.07M | 17.91M | 159.23M | 224.07M | 188.42M | 121.04M | 44.03M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 24.64M | 25.57M |
| Accounts Receivable | 6.34M | 5.08M | 6.83M | 16.57M | 10.03M | 8.99M | 12.63M |
| Days Sales Outstanding | 104.86 | 103.15 | 92.63 | 143.34 | 78.16 | 65.32 | 77.29 |
| Inventory | 3.52M | 5.24M | 4.57M | 7.92M | 12.51M | 14.94M | 16.17M |
| Days Inventory Outstanding | 133.1 | 194.48 | 139.28 | 152.33 | 219.27 | 218.91 | 198.72 |
| Other Current Assets | 0 | 0 | 0 | 60K | 4.66M | 4.18M | 4.66M |
| Total Non-Current Assets | 10.54M | 9.08M | 7.86M | 8.01M | 26.96M | 29.19M | 56.42M |
| Property, Plant & Equipment | 10.01M | 8.57M | 7.14M | 6.79M | 7.04M | 9.57M | 10.33M |
| Fixed Asset Turnover | 2.20x | 2.10x | 3.77x | 6.22x | 6.66x | 5.25x | 5.77x |
| Goodwill | 0 | 0 | 0 | 0 | 10.05M | 10.37M | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 8.49M | 7.86M | 45.26M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 171K | 0 |
| Other Non-Current Assets | 531K | 511K | 723K | 1.23M | 1.38M | 1.22M | 829K |
| Total Assets | 27.75M | 37.66M | 178.83M | 260.91M | 242.59M | 202.98M | 159.48M |
| Asset Turnover | 0.79x | 0.48x | 0.15x | 0.16x | 0.19x | 0.25x | 0.37x |
| Asset Growth % | - | 0.36% | 3.75% | 0.46% | -0.07% | -0.16% | -0.21% |
| Total Current Liabilities | 4.76M | 6.05M | 10.83M | 14.84M | 19.23M | 22.55M | 25.15M |
| Accounts Payable | 645K | 577K | 1M | 1.37M | 1.4M | 1.19M | 2.06M |
| Days Payables Outstanding | 24.37 | 21.43 | 30.61 | 26.38 | 24.48 | 17.45 | 25.35 |
| Short-Term Debt | 0 | 0 | 500K | 0 | 0 | 2.02M | 1.86M |
| Deferred Revenue (Current) | 951K | 1000K | 1000K | 0 | 1000K | 1000K | 1000K |
| Other Current Liabilities | 1.82M | 1.02M | 2.07M | 6.75M | 3.94M | 2.72M | 9.1M |
| Current Ratio | 3.61x | 4.72x | 15.78x | 17.05x | 11.22x | 7.71x | 4.10x |
| Quick Ratio | 2.87x | 3.86x | 15.36x | 16.51x | 10.56x | 7.04x | 3.45x |
| Cash Conversion Cycle | 213.6 | 276.2 | 201.3 | 269.29 | 272.95 | 266.78 | 250.66 |
| Total Non-Current Liabilities | 73.17M | 94.78M | 28.95M | 31.47M | 32.76M | 14.94M | 19.73M |
| Long-Term Debt | 9.65M | 14.77M | 14.33M | 15M | 15M | 0 | 0 |
| Capital Lease Obligations | 7.97M | 6.94M | 5.84M | 4.51M | 3.04M | 3.93M | 4.74M |
| Deferred Tax Liabilities | -8.11M | 0 | 0 | 0 | 2.67M | 2.44M | 2.03M |
| Other Non-Current Liabilities | 55.18M | 72.5M | 194K | 11.96M | 555K | 0 | 2.28M |
| Total Liabilities | 77.92M | 100.83M | 39.79M | 46.3M | 51.99M | 37.49M | 44.88M |
| Total Debt | 17.93M | 22.79M | 21.86M | 20.85M | 19.51M | 5.95M | 6.61M |
| Net Debt | 10.86M | 4.88M | -137.37M | -203.22M | -168.91M | -115.1M | -37.42M |
| Debt / Equity | - | - | 0.16x | 0.10x | 0.10x | 0.04x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | -5.61x | -7.94x | -5.96x | -45.41x | -274.28x | -212.73x | - |
| Total Equity | -50.18M | -63.17M | 139.04M | 214.6M | 190.6M | 165.49M | 114.59M |
| Equity Growth % | - | -0.26% | 3.2% | 0.54% | -0.11% | -0.13% | -0.31% |
| Book Value per Share | -6.18 | -8.39 | 25.35 | 7.68 | 6.05 | 5.13 | 3.36 |
| Total Shareholders' Equity | -50.18M | -63.17M | 139.04M | 214.6M | 190.6M | 165.49M | 114.59M |
| Common Stock | 5K | 5K | 27K | 31K | 32K | 33K | 35K |
| Retained Earnings | -52.28M | -65.65M | -78.47M | -100.64M | -134.2M | -170.6M | -242.81M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.46M | 0 | 0 | 0 | 798K | 1.36M | 1.15M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -8.9M | -11M | 4.13M | -29.08M | -20.93M | -25.06M | -30.25M |
| Operating CF Margin % | -0.4% | -0.61% | 0.15% | -0.69% | -0.45% | -0.5% | -0.51% |
| Operating CF Growth % | - | -0.24% | 1.38% | -8.04% | 0.28% | -0.2% | -0.21% |
| Net Income | -7.54M | -13.37M | -12.82M | -22.17M | -33.56M | -36.4M | -72.21M |
| Depreciation & Amortization | 896K | 900K | 831K | 925K | 1.61M | 2.38M | 4.68M |
| Stock-Based Compensation | 217K | 267K | 525K | 0 | 7.21M | 9.79M | 11.76M |
| Deferred Taxes | 444K | 0 | 0 | 0 | -129K | -305K | -283K |
| Other Non-Cash Items | 208K | 460K | 5.55M | 4.6M | 584K | 1.05M | 28.34M |
| Working Capital Changes | -3.13M | 742K | 10.04M | -12.44M | 3.36M | -1.57M | -2.54M |
| Change in Receivables | 2.53M | 1.26M | -1.82M | -11.28M | 5.93M | 680K | -2.93M |
| Change in Inventory | -989K | -1.86M | 223K | -4.48M | -5.47M | -3.9M | -1.66M |
| Change in Payables | -2.95M | 0 | 0 | 2.75M | 0 | 0 | 0 |
| Cash from Investing | -1.17M | -392K | -9K | -737K | -15.81M | -26.4M | -46.32M |
| Capital Expenditures | -727K | -392K | -9K | -737K | -2.04M | -2.04M | -602K |
| CapEx % of Revenue | 0.03% | 0.02% | 0% | 0.02% | 0.04% | 0.04% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -440K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.99M | 22.24M | 137.19M | 94.72M | 1.18M | -15.94M | -376K |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | 71K | -78K | -1.84M | 93.91M | -374K | -1.87M | -1.52M |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -9.63M | -11.4M | 4.12M | -29.82M | -22.98M | -27.1M | -30.85M |
| FCF Margin % | -0.44% | -0.63% | 0.15% | -0.71% | -0.49% | -0.54% | -0.52% |
| FCF Growth % | - | -0.18% | 1.36% | -8.23% | 0.23% | -0.18% | -0.14% |
| FCF per Share | -1.19 | -1.51 | 0.75 | -1.07 | -0.73 | -0.84 | -0.91 |
| FCF Conversion (FCF/Net Income) | 1.18x | 0.82x | -0.32x | 1.31x | 0.62x | 0.69x | 0.42x |
| Interest Paid | 0 | 1.16M | 913K | 0 | 135K | 0 | 184K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -33.79% | -12.54% | -16.57% | -20.44% | -51.56% |
| Return on Invested Capital (ROIC) | - | - | - | -253.57% | -160.5% | -88.98% | -90.21% |
| Gross Margin | 56.19% | 45.31% | 55.49% | 55.05% | 55.54% | 50.41% | 50.18% |
| Net Margin | -34.17% | -74.41% | -47.66% | -52.53% | -71.64% | -72.47% | -121.09% |
| Debt / Equity | - | - | 0.16x | 0.10x | 0.10x | 0.04x | 0.06x |
| Interest Coverage | -5.61x | -7.94x | -5.96x | -45.41x | -274.28x | -212.73x | - |
| FCF Conversion | 1.18x | 0.82x | -0.32x | 1.31x | 0.62x | 0.69x | 0.42x |
| Revenue Growth | - | -18.51% | 49.64% | 56.93% | 11.01% | 7.21% | 18.72% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Product and service revenue | 14.52M | 16.51M | 49.86M | 59.63M |
| Product and service revenue Growth | - | 13.70% | 201.99% | 19.60% |
| Device Sales | - | - | 33.38M | 35.99M |
| Device Sales Growth | - | - | - | 7.83% |
| Recurring | - | - | 16.48M | 23.32M |
| Recurring Growth | - | - | - | 41.52% |
| Contract | - | - | 370K | 317K |
| Contract Growth | - | - | - | -14.32% |
| Device sales | 33.29M | 28.76M | - | - |
| Device sales Growth | - | -13.61% | - | - |
| Consumables and service | 7.82M | 15.72M | - | - |
| Consumables and service Growth | - | 100.97% | - | - |
| License and contract revenue | 1.1M | 2.38M | - | - |
| License and contract revenue Growth | - | 116.48% | - | - |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| UNITED STATES | - | 37.59M | 38.17M | 41.97M |
| UNITED STATES Growth | - | - | 1.54% | 9.93% |
| Europe, Middle East and Africa | 4.46M | 6.29M | 9.38M | 13.46M |
| Europe, Middle East and Africa Growth | - | 41.14% | 48.98% | 43.56% |
| Asia Pacific | - | 2.89M | 1.82M | 3.34M |
| Asia Pacific Growth | - | - | -36.79% | 83.18% |
| Americas other | - | 76K | 853K | 860K |
| Americas other Growth | - | - | 1022.37% | 0.82% |
908 Devices Inc. (MASS) reported $57.6M in revenue for fiscal year 2024. This represents a 161% increase from $22.1M in 2018.
908 Devices Inc. (MASS) grew revenue by 18.7% over the past year. This is strong growth.
908 Devices Inc. (MASS) reported a net loss of $4.1M for fiscal year 2024.
908 Devices Inc. (MASS) has a return on equity (ROE) of -51.6%. Negative ROE indicates the company is unprofitable.
908 Devices Inc. (MASS) had negative free cash flow of $28.4M in fiscal year 2024, likely due to heavy capital investments.